https://www.madagascarhealthpress.com/article/907218172-triple-green-farms-cbd-gummies-claims-evaluated-the-best-cbd-gummy-formula-on-the-market-under-investigation Madagascar Health Press en PressRelease 2026-04-21T23:41:59+00:00 Triple Green Farms CBD Gummies Claims Evaluated: The Best CBD Gummy Formula on the Market Under Investigation https://zingfast.com/wp-content/uploads/2026/04/Triple-Green-Farms-CBD-Gummies.jpg https://www.madagascarhealthpress.com/article/907217370-kyverna-presents-registrational-trial-primary-analysis-for-miv-cel-in-stiff-person-syndrome-demonstrating-statistically-significant-durable-clinical Madagascar Health Press en PressRelease 2026-04-21T22:45:00+00:00 Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.madagascarhealthpress.com/article/907217864-rnk-health-nad-longevity-therapy-claims-evaluated-the-clinician-guided-nad-injections-medication-protocol Madagascar Health Press en PressRelease 2026-04-21T22:44:56+00:00 RNK Health NAD+ Longevity Therapy Claims Evaluated: The Clinician-Guided NAD Injections & Medication Protocol https://zingfast.com/wp-content/uploads/2026/04/RNK-Health-NAD-Longevity-Therapy.jpg https://www.madagascarhealthpress.com/article/907206353-revolution-medicines-to-present-updated-phase-1-2-clinical-data-for-daraxonrasib-in-first-line-metastatic-pancreatic-cancer-across-monotherapy-and Madagascar Health Press en PressRelease 2026-04-21T21:35:00+00:00 Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.madagascarhealthpress.com/article/907206080-panakeia-unveils-landmark-metabolic-and-pathway-activation-data-in-cancers-at-aacr-2026 Madagascar Health Press en PressRelease 2026-04-21T21:30:00+00:00 Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026 https://ml-eu.globenewswire.com/media/bbe54e9a-e69b-482f-a9b5-f353b9e38434/small/panakeia-logo-high-res-png.png https://www.madagascarhealthpress.com/article/907206303-revolution-medicines-to-present-preclinical-data-on-innovative-mutant-targeted-catalytic-ras-on-inhibitor-at-the-2026-aacr-annual-meeting Madagascar Health Press en PressRelease 2026-04-21T21:30:00+00:00 Revolution Medicines to Present Preclinical Data on Innovative Mutant-Targeted Catalytic RAS(ON) Inhibitor at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.madagascarhealthpress.com/article/907206411-zymeworks-presents-new-phase-1-data-for-zw191-a-folate-receptor-alpha-targeting-adc-at-aacr-annual-meeting-2026 Madagascar Health Press en PressRelease 2026-04-21T21:30:00+00:00 Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png https://www.madagascarhealthpress.com/article/907206856-bbot-presents-preclinical-data-showing-ras-pi3k-breaker-bbo-10203-inhibits-pi3k-akt-signaling-in-her2amp-models-at-the-aacr-annual-meeting-2026 Madagascar Health Press en PressRelease 2026-04-21T21:30:00+00:00 BBOT Presents Preclinical Data Showing RAS:PI3Kα Breaker BBO-10203 Inhibits PI3Kα/AKT Signaling in HER2AMP Models at the AACR Annual Meeting 2026 https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://www.madagascarhealthpress.com/article/907207103-aktis-oncology-announces-presentation-of-first-clinical-imaging-and-dosimetry-data-for-aky-2519-at-the-2026-american-society-of-clinical-oncology Madagascar Health Press en PressRelease 2026-04-21T21:00:00+00:00 Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://www.madagascarhealthpress.com/article/907199383-prostact-global-phase-3-part-1-selected-as-late-breaking-abstract-at-asco-2026 Madagascar Health Press en PressRelease 2026-04-21T20:49:14+00:00 ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026 https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.madagascarhealthpress.com/article/907198800-intuitive-announces-first-quarter-earnings Madagascar Health Press en PressRelease 2026-04-21T20:38:28+00:00 Intuitive Announces First Quarter Earnings https://ml.globenewswire.com/media/db89f2a9-76ed-4743-84d3-a7ac75605b6c/small/logo-jpg.jpg https://www.madagascarhealthpress.com/article/907196167-ascendis-announces-redemption-of-all-575-million-of-outstanding-2-25-convertible-senior-notes-due-2028 Madagascar Health Press en PressRelease 2026-04-21T20:31:00+00:00 Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028 https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png https://www.madagascarhealthpress.com/article/907195144-steris-to-host-a-conference-call-for-fiscal-2026-fourth-quarter-and-full-year-results-on-may-12-2026 Madagascar Health Press en PressRelease 2026-04-21T20:30:00+00:00 STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026 https://ml.globenewswire.com/media/2c1a9c6d-bc94-4d3f-a47f-0ac0d209f8b6/small/sterishoriz-no-r-rgb-jpg-jpg.jpg https://www.madagascarhealthpress.com/article/907195728-rgenta-therapeutics-announces-rgt-61159-clinical-poster-presentation-at-the-upcoming-2026-american-society-of-clinical-oncology-asco-annual-meeting Madagascar Health Press en PressRelease 2026-04-21T20:30:00+00:00 Rgenta Therapeutics Announces RGT-61159 Clinical Poster Presentation at the Upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/de2f6450-22c4-4c16-b785-04cea917de03/small/rgenta-logo-fullcolor-print-1-png.png https://www.madagascarhealthpress.com/article/907195765-fennec-pharmaceuticals-announces-acceptance-of-abstracts-at-the-2026-asco-annual-meeting Madagascar Health Press en PressRelease 2026-04-21T20:30:00+00:00 Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/2eeb9b85-0beb-4bbe-a7af-1c0e9403db44/small/fennec-logo-png.png https://www.madagascarhealthpress.com/article/907198302-rapport-therapeutics-presents-rap-219-focal-onset-seizure-phase-2a-follow-up-period-results-demonstrating-sustained-seizure-reduction-at-the-2026 Madagascar Health Press en PressRelease 2026-04-21T20:30:00+00:00 Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting https://ml.globenewswire.com/media/7777ee9b-f88b-4a59-a668-d81520f9d32c/small/rapport-logo-color-rgb-png.png https://www.madagascarhealthpress.com/article/907195487-autolus-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Madagascar Health Press en PressRelease 2026-04-21T20:10:00+00:00 Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png https://www.madagascarhealthpress.com/article/907196098-cytodyn-completes-enrollment-in-phase-2-metastatic-colorectal-cancer-study Madagascar Health Press en PressRelease 2026-04-21T20:10:00+00:00 CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://www.madagascarhealthpress.com/article/907194566-oculis-publishes-invitation-to-the-annual-general-meeting Madagascar Health Press en PressRelease 2026-04-21T20:05:00+00:00 Oculis Publishes Invitation to the Annual General Meeting https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.madagascarhealthpress.com/article/907194817-tela-bio-to-announce-first-quarter-2026-financial-results Madagascar Health Press en PressRelease 2026-04-21T20:05:00+00:00 TELA Bio to Announce First Quarter 2026 Financial Results https://ml.globenewswire.com/media/62aad9be-813a-415e-990b-f27442cbec50/small/download-png.png https://www.madagascarhealthpress.com/article/907195040-foghorn-therapeutics-presents-new-preclinical-data-for-selective-smarca2-inhibitor-fhd-909-and-for-selective-cbp-ep300-and-arid1b-degrader-programs Madagascar Health Press en PressRelease 2026-04-21T20:05:00+00:00 Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg https://www.madagascarhealthpress.com/article/907195220-madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4 Madagascar Health Press en PressRelease 2026-04-21T20:05:00+00:00 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907195389-sight-sciences-to-report-first-quarter-2026-financial-results-on-may-6-2026 Madagascar Health Press en PressRelease 2026-04-21T20:05:00+00:00 Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/e7536623-9fa4-42d0-896d-04ddb984ef4e/small/sght-logo-png.png https://www.madagascarhealthpress.com/article/907195483-opko-health-to-report-first-quarter-2026-financial-results-on-april-28-2026 Madagascar Health Press en PressRelease 2026-04-21T20:05:00+00:00 OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026 https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://www.madagascarhealthpress.com/article/907195631-immuneering-to-present-new-survival-data-from-first-line-pancreatic-cancer-patients-treated-with-atebimetinib-mgnp-in-an-oral-presentation-at-the Madagascar Health Press en PressRelease 2026-04-21T20:05:00+00:00 Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg https://www.madagascarhealthpress.com/article/907195990-pharmala-issues-q2-financial-statements-and-grants-options Madagascar Health Press en PressRelease 2026-04-21T20:05:00+00:00 PharmAla Issues Q2 Financial Statements and Grants Options https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png https://www.madagascarhealthpress.com/article/907194936-beta-bionics-announces-first-quarter-2026-financial-results-and-raises-full-year-2026-guidance Madagascar Health Press en PressRelease 2026-04-21T20:03:00+00:00 Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance https://ml.globenewswire.com/media/88df4d95-789c-467a-8481-f67e19e1adfa/small/beta-bionics-logo-2color-1200-png.png https://www.madagascarhealthpress.com/article/907195346-olema-oncology-to-present-initial-clinical-data-for-op-3136-at-the-2026-asco-annual-meeting Madagascar Health Press en PressRelease 2026-04-21T20:01:00+00:00 Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://www.madagascarhealthpress.com/article/907195777-wave-life-sciences-announces-hearing-on-proposed-redomiciliation-to-the-united-states Madagascar Health Press en PressRelease 2026-04-21T20:01:00+00:00 Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907195385-belite-bio-initiates-rolling-submission-of-new-drug-application-to-the-u-s-food-and-drug-administration-for-tinlarebant-for-the-treatment-of Madagascar Health Press en PressRelease 2026-04-21T20:00:00+00:00 Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease https://ml.globenewswire.com/media/7f86ac70-6347-41c6-a622-e7000c42ad35/small/belite-bio-logo-digital-full-color-png.png https://www.madagascarhealthpress.com/article/907195482-cytokinetics-to-announce-first-quarter-results-on-may-5-2026 Madagascar Health Press en PressRelease 2026-04-21T20:00:00+00:00 Cytokinetics to Announce First Quarter Results on May 5, 2026 https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.madagascarhealthpress.com/article/907197041-neuro-salt-ingredients-decoded-deciphering-the-difference-between-official-website-hype-actual-health-benefits Madagascar Health Press en PressRelease 2026-04-21T19:44:53+00:00 Neuro Salt Ingredients Decoded: Deciphering the Difference Between Official Website Hype & Actual Health Benefits https://zingfast.com/wp-content/uploads/2026/04/Neuro-Salt-Ingredients.jpg https://www.madagascarhealthpress.com/article/907196452-premier-health-announces-management-transition Madagascar Health Press en PressRelease 2026-04-21T19:38:07+00:00 Premier Health Announces Management Transition https://ml.globenewswire.com/media/b01bbc61-42f9-4000-9a0a-b1d6719f7396/small/pha-logo-png.png https://www.madagascarhealthpress.com/article/907183356-precede-biosciences-launches-precede-bio-insight-a-genome-wide-liquid-biopsy-for-functional-tumor-biology-at-aacr-2026 Madagascar Health Press en PressRelease 2026-04-21T18:30:00+00:00 Precede Biosciences Launches Precede Bio Insight™, a Genome-Wide Liquid Biopsy for Functional Tumor Biology at AACR 2026 https://ml.globenewswire.com/media/adc7102a-f715-445b-9532-23260281465e/small/logo-png.png https://www.madagascarhealthpress.com/article/907183453-vapofil-claims-evaluated-2026-official-website-scam-warning-update-avoid-fake-complaints-hidden-risks Madagascar Health Press en PressRelease 2026-04-21T18:28:42+00:00 Vapofil Claims Evaluated (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks https://zingfast.com/wp-content/uploads/2026/04/Vapofil-Scam.jpg https://www.madagascarhealthpress.com/article/907173076-ai-enhanced-medical-ventilators-drive-healthcare-digitization-as-investment-in-respiratory-care-technology-surges Madagascar Health Press en PressRelease 2026-04-21T17:43:52+00:00 AI-Enhanced Medical Ventilators Drive Healthcare Digitization as Investment in Respiratory Care Technology Surges https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.madagascarhealthpress.com/article/907162998-nipsapp-game-studios-announces-ai-driven-vr-solutions-for-surgical-training-and-nuclear-safety Madagascar Health Press en PressRelease 2026-04-21T16:24:00+00:00 NipsApp Game Studios Announces AI-Driven VR Solutions for Surgical Training and Nuclear Safety https://pressranger.s3.us-west-1.amazonaws.com/3234700/The-Hindu.jpg https://www.madagascarhealthpress.com/article/907163482-bronson-methodist-hospital-named-no-1-academic-medical-center-in-the-nation-earns-premier-100-top-hospital-honor Madagascar Health Press en PressRelease 2026-04-21T16:22:31+00:00 Bronson Methodist Hospital Named No. 1 Academic Medical Center in the Nation; Earns Premier 100 Top Hospital® Honor https://ml.globenewswire.com/media/e43d0be7-916a-4886-81e2-27ca4942b827/medium/bronson-methodist-hospital-in-kalamazoo-mich.JPG https://www.madagascarhealthpress.com/article/907162698-avacta-data-at-aacr-2026-underline-favorable-profile-of-ava6103-and-advantages-of-pre-cision-delivery-platform Madagascar Health Press en PressRelease 2026-04-21T16:00:00+00:00 Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform https://ml.globenewswire.com/media/63584766-21c6-42e8-944c-7103432b045b/small/avacta-logo-full-color-rgb-oct-2024-jpg.jpg https://www.madagascarhealthpress.com/article/907162851-intermountain-health-primary-children-s-hospital-in-lehi-utah-is-already-expanding Madagascar Health Press en PressRelease 2026-04-21T15:37:45+00:00 Intermountain Health Primary Children’s Hospital in Lehi, Utah is Already Expanding https://ml.globenewswire.com/media/YTRjYjVlNmQtZmVmYy00NDhmLTgyZDUtZTlmNzk0NmJhOWY3LTEyNjkxMjYtMjAyNi0wNC0yMS1lbg==/tiny/Intermountain-Health.png https://www.madagascarhealthpress.com/article/907153789-revolution-medicines-to-present-pivotal-phase-3-rasolute-302-clinical-trial-results-for-daraxonrasib-in-previously-treated-metastatic-pancreatic Madagascar Health Press en PressRelease 2026-04-21T15:23:01+00:00 Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.madagascarhealthpress.com/article/907153350-becoming-independent-named-no-17-on-the-nonprofit-times-2026-best-nonprofits-to-work-for Madagascar Health Press en PressRelease 2026-04-21T15:15:00+00:00 Becoming Independent Named No. 17 on “The NonProfit Times' 2026 Best Nonprofits To Work For” https://ml.globenewswire.com/media/58d05702-9c01-4ca3-9d17-7d25146c5587/small/bi-logo-pack-green-cmyk-249kb-jpg.jpg https://www.madagascarhealthpress.com/article/907153044-record-breaking-springfest-2026-affirms-a4m-as-the-central-forum-for-longevity-medicine Madagascar Health Press en PressRelease 2026-04-21T15:00:00+00:00 Record-Breaking SpringFest 2026 Affirms A4M as the Central Forum for Longevity Medicine https://ml.globenewswire.com/media/OWM2NDdhZTQtNzY2Ny00Y2MzLWFmY2ItYmIzODMxNTJjOTNlLTUwMDEyODY4NS0yMDI2LTA0LTIxLWVu/tiny/American-Academy-of-Anti-Aging.png https://www.madagascarhealthpress.com/article/907153774-remix-therapeutics-announces-oral-presentation-of-first-in-class-small-molecule-myb-mrna-degrader-rem-422-phase-1-2-aria-trial-results-at-the-2026 Madagascar Health Press en PressRelease 2026-04-21T15:00:00+00:00 Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ARIA Trial Results at the 2026 American Society of Clinical Oncology Annual Meeting https://ml.globenewswire.com/media/4facea87-f600-4440-a295-a31bb083c9bd/small/remix-logo-png.png https://www.madagascarhealthpress.com/article/907152791-xeltis-releases-groundbreaking-new-12-month-eu-pivotal-data-for-axess-demonstrating-the-transformative-potential-in-hemodialysis-treatment Madagascar Health Press en PressRelease 2026-04-21T14:50:00+00:00 Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment https://ml-eu.globenewswire.com/media/dee0d6ab-8850-4503-bdcd-ede435e96729/small/xeltis-youtube-logo-high-res-002-png.png https://www.madagascarhealthpress.com/article/907152903-trethera-announces-appointment-of-m-andrew-drew-woodmansee-to-board-of-directors Madagascar Health Press en PressRelease 2026-04-21T14:42:00+00:00 Trethera Announces Appointment of M. Andrew (“Drew”) Woodmansee to Board of Directors https://ml.globenewswire.com/media/2a7ea251-6a26-4ee9-97cf-a9dda8ccba1d/small/picture1-jpg.jpg https://www.madagascarhealthpress.com/article/907153754-black-diamond-therapeutics-announces-oral-presentation-of-silevertinib-phase-2-data-in-frontline-egfrm-nsclc-patients-at-the-2026-asco-annual-meeting Madagascar Health Press en PressRelease 2026-04-21T14:40:00+00:00 Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png https://www.madagascarhealthpress.com/article/907152854-itm-to-announce-quality-of-life-data-from-the-phase-3-compete-trial-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-at-asco Madagascar Health Press en PressRelease 2026-04-21T14:30:22+00:00 ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026 https://ml-eu.globenewswire.com/media/3411c2bd-01a5-4d06-ad90-4a6e168bad61/small/itm-logo-claim-rgb-high-res-png.png https://www.madagascarhealthpress.com/article/907152828-glp-diet-app-launches-personalized-wellness-app-for-glp-1-medication-users-earns-2-500-app-reviews Madagascar Health Press en PressRelease 2026-04-21T14:30:00+00:00 GLP Diet App Launches Personalized Wellness App for GLP-1 Medication Users, Earns 2,500+ App Reviews https://ml-eu.globenewswire.com/media/14da2855-c153-4f17-98b5-0b26ef17f7be/medium/glp-diet-is-gaining-popularity.png https://www.madagascarhealthpress.com/article/907153563-global-virus-network-on-measles-resurgence Madagascar Health Press en PressRelease 2026-04-21T14:30:00+00:00 Global Virus Network on Measles Resurgence https://ml.globenewswire.com/media/6c1b2724-7b9b-469a-a7c3-bc0a64d716ae/small/gvn-lt-gr-gradiant-jpg.jpg https://www.madagascarhealthpress.com/article/907153590-cemdisiran-dosed-subcutaneously-every-12-weeks-demonstrates-rapid-deep-and-sustained-disease-control-in-generalized-myasthenia-gravis-gmg-phase-3 Madagascar Health Press en PressRelease 2026-04-21T14:30:00+00:00 Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907153661-zentalis-pharmaceuticals-announces-abstract-acceptance-at-asco-2026-featuring-azenosertib-in-combination-with-paclitaxel-for-platinum-resistant Madagascar Health Press en PressRelease 2026-04-21T14:27:05+00:00 Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer https://ml.globenewswire.com/media/1b481d6d-51c9-44f0-b33f-81feb1061d2e/small/zentalis-logo-png.png https://www.madagascarhealthpress.com/article/907152848-immatics-announces-four-upcoming-oral-presentations-across-its-clinical-cell-therapy-and-bispecific-portfolio-at-2026-asco-annual-meeting Madagascar Health Press en PressRelease 2026-04-21T14:25:55+00:00 Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting https://ml-eu.globenewswire.com/media/1ef1cd0c-384c-4889-82c8-58bd42054fb8/small/immatics-final-logo-r-white-background-png.png https://www.madagascarhealthpress.com/article/907144469-nextcure-and-simcere-s-sim0505-cdh6-adc-phase-1-data-to-be-presented-at-asco-2026 Madagascar Health Press en PressRelease 2026-04-21T14:15:00+00:00 NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026 https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg https://www.madagascarhealthpress.com/article/907145392-aprea-therapeutics-to-provide-clinical-update-on-acesot-1051-phase-1-trial-evaluating-wee1-inhibitor-apr-1051-at-asco-2026-annual-meeting Madagascar Health Press en PressRelease 2026-04-21T14:15:00+00:00 Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907144128-4bio-capital-portfolio-company-ray-therapeutics-announces-upsized-and-oversubscribed-125-million-series-b-financing-for-vision-restoration-treatments Madagascar Health Press en PressRelease 2026-04-21T14:13:17+00:00 4BIO Capital portfolio company Ray Therapeutics announces upsized and oversubscribed $125 Million Series B financing for vision restoration treatments https://ml-eu.globenewswire.com/media/fab6412c-5edc-4903-8a71-51e5ccc6accb/small/4bio-capital-logo-png.png https://www.madagascarhealthpress.com/article/907144122-impact-biotech-announces-upcoming-data-presentations-for-padeliporfin-vtp-at-aua-and-asco-2026 Madagascar Health Press en PressRelease 2026-04-21T14:00:00+00:00 ImPact Biotech Announces Upcoming Data Presentations for Padeliporfin VTP at AUA and ASCO 2026 https://ml-eu.globenewswire.com/media/68762066-1fff-4065-af45-d18da25273cd/small/impact-biotech-logo-final-resized-jpg.jpg https://www.madagascarhealthpress.com/article/907144129-concerned-about-supporting-erectile-health-life-extension-launches-new-men-s-sexual-health-supplement Madagascar Health Press en PressRelease 2026-04-21T14:00:00+00:00 Concerned About Supporting Erectile Health? Life Extension Launches New Men’s Sexual Health Supplement https://ml.globenewswire.com/media/MGZmYTU5YWUtNGU0Ny00YWNhLWJjZDktNjc2NTBhMThjNzcwLTEyMDU5MDYtMjAyNi0wNC0yMS1lbg==/tiny/Life-Extension.png https://www.madagascarhealthpress.com/article/907144137-dewpoint-therapeutics-reports-preclinical-data-on-oral-myc-condensate-modulator-at-aacr-2026 Madagascar Health Press en PressRelease 2026-04-21T14:00:00+00:00 Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026 https://ml.globenewswire.com/media/e6f24195-bede-49a6-a925-b7dceea78e57/small/dewpoint-logo-centered-full-color-png.png https://www.madagascarhealthpress.com/article/907144152-cardiff-oncology-to-present-updated-phase-2-data-of-onvansertib-in-first-line-ras-mutated-mcrc-in-a-rapid-oral-session-at-asco-2026 Madagascar Health Press en PressRelease 2026-04-21T14:00:00+00:00 Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026 https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg https://www.madagascarhealthpress.com/article/907144160-disc-medicine-announces-oral-presentation-of-data-from-rally-mf-phase-2-trial-of-disc-0974-in-patients-with-myelofibrosis-and-anemia-at-the-american Madagascar Health Press en PressRelease 2026-04-21T14:00:00+00:00 Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://www.madagascarhealthpress.com/article/907144227-cellectar-biosciences-announces-subset-of-clover-wam-clinical-trial-data-accepted-for-presentation-at-the-american-society-of-clinical-oncology Madagascar Health Press en PressRelease 2026-04-21T14:00:00+00:00 Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026 https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg https://www.madagascarhealthpress.com/article/907144231-actg-launches-critical-study-evaluating-hormone-therapy-for-women-living-with-hiv-in-the-menopause-transition Madagascar Health Press en PressRelease 2026-04-21T14:00:00+00:00 ACTG Launches Critical Study Evaluating Hormone Therapy for Women Living with HIV in the Menopause Transition https://ml.globenewswire.com/media/1e94313a-1d33-49e8-bd5e-fd0c911661c9/small/image1-png.png https://www.madagascarhealthpress.com/article/907145205-leads-biolabs-pd-l1-4-1bb-bispecific-antibody-opamtistomig-lbl-024-enters-phase-trial-with-first-patient-dosing-in-gastric-cancer-pioneering Madagascar Health Press en PressRelease 2026-04-21T13:47:09+00:00 Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies https://ml.globenewswire.com/media/MGZhMTI3YWEtMDgwZS00ZGVlLTg5MzItYjQxOWI5ODY4Mjc3LTEzMDgzODktMjAyNi0wNC0yMS1lbg==/tiny/LEADS-BIOLABS-CO-LTD-.png https://www.madagascarhealthpress.com/article/907144731-lachine-hospital-foundation-gala-raises-322-115-to-transform-health-care-in-the-west-island Madagascar Health Press en PressRelease 2026-04-21T13:31:17+00:00 Lachine Hospital Foundation Gala raises $322,115 to transform health care in the West Island https://ml.globenewswire.com/media/12f4e9fa-5811-4a1a-a134-b657bc1e4000/medium/lachine-hospital-foundation-gala-raises-322-115-to-transform.jpg https://www.madagascarhealthpress.com/article/907144804-le-gala-de-la-fondation-de-l-h-pital-de-lachine-recueille-322-115-pour-transformer-les-soins-de-sant-dans-l-ouest-de-l-le Madagascar Health Press en PressRelease 2026-04-21T13:31:17+00:00 Le Gala de la Fondation de l’Hôpital de Lachine recueille 322 115 $ pour transformer les soins de santé dans l’Ouest-de-l’Île https://ml.globenewswire.com/media/12f4e9fa-5811-4a1a-a134-b657bc1e4000/medium/le-gala-de-la-fondation-de-lhopital-de-lachine-recueille-322.jpg https://www.madagascarhealthpress.com/article/907144126-focus-on-french-healthtech-s-ecosystem-panorama-france-healthtech-2026-s-review-a-mature-innovative-and-resilient-sector-facing-a-more-demanding Madagascar Health Press en PressRelease 2026-04-21T13:30:00+00:00 Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment https://ml-eu.globenewswire.com/media/NDZkYjRhMmYtYzk2Ny00YTE0LTkxNzgtMDkyYTIzM2ZkMTgyLTEyNjc2MjAtMjAyNi0wNC0yMS1lbg==/tiny/FP2COM.png https://www.madagascarhealthpress.com/article/907144221-qhslab-otcqb-usaq-reports-127-year-over-year-isp-growth-and-launches-q-connect-glp-1-support-assessment Madagascar Health Press en PressRelease 2026-04-21T13:15:00+00:00 QHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support Assessment  https://ml.globenewswire.com/media/52b3dc5d-608c-487d-8b43-a4dfa1155e15/small/logo-png.png https://www.madagascarhealthpress.com/article/907144625-eclipse-energy-and-wood-to-scale-hydrogen-production-from-end-of-life-oil-fields Madagascar Health Press en PressRelease 2026-04-21T13:15:00+00:00 Eclipse Energy and Wood to Scale Hydrogen Production from End-of-Life Oil Fields https://ml.globenewswire.com/media/ffa0146b-9ebf-479c-865b-d6e55e0e9adc/small/eclipse-hero-vertical-blk-lg-png.png https://www.madagascarhealthpress.com/article/907136324-outlook-therapeutics-completes-federal-dispute-resolution-fdr-meeting-with-fda-for-ons-5010-lytenava-bevacizumab-vikg Madagascar Health Press en PressRelease 2026-04-21T13:05:00+00:00 Outlook Therapeutics Completes Federal Dispute Resolution (FDR) Meeting with FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg) https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png https://www.madagascarhealthpress.com/article/907136334-pacbio-and-lucid-genomics-announce-compatibility-collaboration-to-advance-tertiary-analysis-for-long-read-sequencing Madagascar Health Press en PressRelease 2026-04-21T13:05:00+00:00 PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://www.madagascarhealthpress.com/article/907135218-stereotaxis-to-report-first-quarter-2026-financial-results-on-may-12-2026 Madagascar Health Press en PressRelease 2026-04-21T13:01:00+00:00 Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026 https://ml.globenewswire.com/media/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3/small/stereotaxis-logo-new-tagline-black-text-png.png https://www.madagascarhealthpress.com/article/907134970-world-s-fastest-hiv-test-added-to-the-together-takemehome-program-for-free-at-home-hiv-self-testing-across-the-united-states Madagascar Health Press en PressRelease 2026-04-21T13:00:00+00:00 World’s Fastest HIV Test added to the Together TakeMeHome Program for Free at Home HIV Self-Testing Across the United States https://ml.globenewswire.com/media/75685099-6350-45fb-b96d-e7dea96bbf55/medium/at-home-hiv-testing-made-simple.jpg https://www.madagascarhealthpress.com/article/907135193-new-bay-area-lyme-foundation-study-shows-common-fda-cleared-lyme-tests-miss-64-78-of-early-cases-underscores-urgent-need-for-improved-diagnostics Madagascar Health Press en PressRelease 2026-04-21T13:00:00+00:00 New Bay Area Lyme Foundation Study Shows Common FDA-Cleared Lyme Tests Miss 64-78% of Early Cases, Underscores Urgent Need for Improved Diagnostics https://ml.globenewswire.com/media/388871d3-1a1a-48cf-8ebf-c08773485acd/small/bay-area-logo-0425-png.png https://www.madagascarhealthpress.com/article/907135221-aux-labs-secures-4m-to-commercialize-precision-fermentation-cheese-platform Madagascar Health Press en PressRelease 2026-04-21T13:00:00+00:00 AuX Labs Secures $4M to Commercialize Precision Fermentation Cheese Platform https://ml.globenewswire.com/media/8c024de8-d111-4d2f-8a46-7a0cec7f980c/medium/aux-labs-mozzarella.jpg https://www.madagascarhealthpress.com/article/907135605-lice-clinics-of-america-longmont-hosts-annual-easter-egg-hunt-with-free-lice-checks-treatments Madagascar Health Press en PressRelease 2026-04-21T13:00:00+00:00 Lice Clinics of America – Longmont Hosts Annual Easter “Egg Hunt” with Free Lice Checks & Treatments https://ml.globenewswire.com/media/OTQ4ZjJlMDktMWNjMC00MTc1LWE3MTYtMmQxNTI4MTVmYTM4LTEyNzQ4MjQtMjAyNi0wNC0yMS1lbg==/tiny/Lice-Clinics-of-America.png https://www.madagascarhealthpress.com/article/907135833-akari-therapeutics-asco-abstract-acceptance-highlights-potential-for-aktx-101-adc-to-treat-kras-mutant-tumors Madagascar Health Press en PressRelease 2026-04-21T13:00:00+00:00 Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.madagascarhealthpress.com/article/907136206-twentyeight-health-launches-first-nationwide-all-in-one-virtual-clinic-personalized-care-for-women Madagascar Health Press en PressRelease 2026-04-21T13:00:00+00:00 Twentyeight Health Launches First Nationwide All-in-One Virtual Clinic & Personalized Care for Women https://ml.globenewswire.com/media/ab364761-0cc6-4c5e-9483-815a4f74e08a/small/twentyeight-health-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907136441-brain-cancer-canada-marks-brain-cancer-awareness-month-in-may-with-national-landmark-lightings-community-events-new-research-investments-and-a-call Madagascar Health Press en PressRelease 2026-04-21T13:00:00+00:00 Brain Cancer Canada Marks Brain Cancer Awareness Month in May with National Landmark Lightings, Community Events, New Research Investments, and a Call to Action https://ml.globenewswire.com/media/78a73b7f-a470-42a5-9976-aa425939a68b/small/bcc-logo-2024-png.png https://www.madagascarhealthpress.com/article/907137563-nexgel-new-strategic-partner-sequence-lifescience-leads-financing-with-5-5-million-to-complete-acquisition-of-celularity-degenerative-disease Madagascar Health Press en PressRelease 2026-04-21T13:00:00+00:00 NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://www.madagascarhealthpress.com/article/907137450-fortrea-announces-date-for-first-quarter-2026-financial-results-and-conference-call Madagascar Health Press en PressRelease 2026-04-21T12:45:00+00:00 Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call https://ml.globenewswire.com/media/9fbbe00b-8782-464e-83e6-5843c563884a/small/fortrea-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907136452-moleculin-announces-abstract-accepted-for-poster-presentation-at-the-2026-asco-annual-meeting Madagascar Health Press en PressRelease 2026-04-21T12:36:00+00:00 Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://www.madagascarhealthpress.com/article/907135060-neuronetics-to-report-first-quarter-2026-financial-and-operating-results-and-host-conference-call Madagascar Health Press en PressRelease 2026-04-21T12:30:00+00:00 Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png https://www.madagascarhealthpress.com/article/907136327-oncotelic-therapeutics-inc-otcqb-otlc-leveraging-expertise-amid-evaluation-evolution Madagascar Health Press en PressRelease 2026-04-21T12:30:00+00:00 Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation Evolution https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.madagascarhealthpress.com/article/907136328-journey-medical-corporation-secures-contract-with-third-major-gpo-for-emrosi Madagascar Health Press en PressRelease 2026-04-21T12:30:00+00:00 Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™ https://ml.globenewswire.com/media/68f0b467-248f-4250-9cda-2c7a68a11a1d/small/journeylogo-1-jpg.jpg https://www.madagascarhealthpress.com/article/907136365-milestone-scientific-inc-completes-2-15-million-private-placement Madagascar Health Press en PressRelease 2026-04-21T12:30:00+00:00 Milestone Scientific Inc. Completes $2.15 Million Private Placement https://ml.globenewswire.com/media/408ad3c5-6ad3-41bd-9763-356666216796/small/milestonelogo-rgb-final-jpg.jpg https://www.madagascarhealthpress.com/article/907136403-allogene-therapeutics-expands-pivotal-phase-2-alpha3-trial-to-south-korea-and-australia Madagascar Health Press en PressRelease 2026-04-21T12:30:00+00:00 Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.madagascarhealthpress.com/article/907136426-celularity-announces-closing-of-transaction-with-nexgel Madagascar Health Press en PressRelease 2026-04-21T12:30:00+00:00 Celularity Announces Closing of Transaction with NexGel https://ml.globenewswire.com/media/ZDdlZDY3ZmYtNGQwNi00M2U2LWFiZGQtYjdkODg0YjNiMzFhLTEyMTY1NjItMjAyNi0wNC0yMS1lbg==/tiny/Celularity-Inc-.png https://www.madagascarhealthpress.com/article/907136433-polaryx-therapeutics-receives-u-s-fda-fast-track-designations-for-all-four-indications-to-be-evaluated-in-the-soteria-basket-trial Madagascar Health Press en PressRelease 2026-04-21T12:30:00+00:00 Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial https://ml.globenewswire.com/media/64e2f507-40e8-46aa-b22e-6661e7035467/small/polaryx-logonew-png.png https://www.madagascarhealthpress.com/article/907136438-enlivex-announces-second-regulatory-approval-for-phase-2b-trial-of-allocetra-in-age-related-primary-moderate-to-severe-knee-osteoarthritis Madagascar Health Press en PressRelease 2026-04-21T12:30:00+00:00 Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://www.madagascarhealthpress.com/article/907136846-cristcot-announces-fda-acceptance-of-nda-for-next-generation-hydrocortisone-acetate-nghca-for-treatment-of-ulcerative-colitis-uc-of-the-rectum Madagascar Health Press en PressRelease 2026-04-21T12:30:00+00:00 Cristcot Announces FDA Acceptance of NDA for Next-Generation Hydrocortisone Acetate (ngHCA) for Treatment of Ulcerative Colitis (UC) of the Rectum https://ml.globenewswire.com/media/ZjcwNjEwOGEtZWEwZi00MTJkLWEzODgtYTFjYTIzYTlhMWI1LTEzMjI0MTAtMjAyNi0wNC0yMS1lbg==/tiny/Cristcot-HD-LLC.png https://www.madagascarhealthpress.com/article/907136773-bioaegis-therapeutics-announces-collaboration-with-prenosis-to-advance-ai-driven-precision-medicine-in-inflammatory-disease Madagascar Health Press en PressRelease 2026-04-21T12:19:30+00:00 BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease https://ml.globenewswire.com/media/0f901467-27cb-4506-a92d-a4f910b78919/small/bioaegis-therapeutics-logo-2-5-x-5-150-pixel-jpg.jpg https://www.madagascarhealthpress.com/article/907126427-new-data-for-smith-nephew-s-cartiheal-agili-c-cartilage-repair-implant-demonstrates-superior-pain-relief-and-functional-gains-at-5-years Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years https://ml-eu.globenewswire.com/media/8512c693-36e3-49c5-9341-0e33875d614d/small/s-n-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907126485-innovage-to-announce-fiscal-third-quarter-2026-financial-results-and-host-conference-call-tuesday-may-5-2026 Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 InnovAge to Announce Fiscal Third Quarter 2026 Financial Results and Host Conference Call Tuesday, May 5, 2026 https://ml.globenewswire.com/media/a1b976fe-053f-43be-b43c-532393a7f314/small/inn-logotag-rgb-jpg.jpg https://www.madagascarhealthpress.com/article/907126536-allarity-therapeutics-presents-two-aacr-2026-posters-highlighting-stenoparib-s-potential-in-colorectal-cancer-as-well-as-new-predictive-data-linking Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 Allarity Therapeutics Presents Two AACR 2026 Posters Highlighting Stenoparib’s Potential in Colorectal Cancer as well as New Predictive Data Linking DRP® and Overall Survival in Ovarian Cancer https://ml-eu.globenewswire.com/media/fd1e4c64-f0cf-40e0-a0c9-0be0d6dce544/small/allarity-full-color-rgb-2023jun07-png.png https://www.madagascarhealthpress.com/article/907126549-catheter-precision-secures-u-s-patent-allowance-on-foundational-surgical-technology-establishing-powerful-ip-and-accelerating-scalable-growth Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://www.madagascarhealthpress.com/article/907126551-spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium https://ml.globenewswire.com/media/195ccecc-f977-4fb5-ba01-43af7ec47589/small/spur-therapeutics-black-wopacity-rgb-png.png https://www.madagascarhealthpress.com/article/907126628-krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026 Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026 https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png https://www.madagascarhealthpress.com/article/907126797-glucotrack-announces-publication-of-peer-reviewed-study-supporting-long-life-sensor-design-for-implantable-continuous-blood-glucose-monitoring Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology https://ml.globenewswire.com/media/3e47bd1b-0cc6-4104-b91d-0ddb9f30f4cc/small/gt-logo-png.png https://www.madagascarhealthpress.com/article/907126942-calidi-biotherapeutics-presents-new-data-on-its-lead-asset-cld-401-at-the-aacr-annual-meeting-in-april-2026 Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 Calidi Biotherapeutics Presents New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026 https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.madagascarhealthpress.com/article/907127048-cogent-biosciences-announces-oral-presentation-of-positive-phase-3-peak-trial-in-gastrointestinal-stromal-tumors-gist-at-the-2026-american-society Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://www.madagascarhealthpress.com/article/907127417-humacyte-announces-israeli-ministry-of-health-acceptance-of-marketing-authorization-application-for-symvess-for-vascular-trauma-repair Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://www.madagascarhealthpress.com/article/907128279-vystar-and-r3alm-launch-r3alm-com-following-strategic-transaction Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 Vystar and R3alm Launch R3alm.com Following Strategic Transaction https://ml.globenewswire.com/media/08188699-078a-4d6e-ae46-c56120bb0435/small/logo-jpg.jpg https://www.madagascarhealthpress.com/article/907128499-biorestorative-therapies-announces-strategic-partnership-with-global-dermatology-leader-dr-david-j-goldberg-to-lead-clinical-evaluation-and-seek Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform https://ml.globenewswire.com/media/a9a09a16-9f91-466d-a0b4-2a7f2fd05ebe/small/logo-png.png https://www.madagascarhealthpress.com/article/907128519-patchmd-appoints-bradley-keys-as-chief-marketing-officer Madagascar Health Press en PressRelease 2026-04-21T12:00:00+00:00 PatchMD Appoints Bradley Keys as Chief Marketing Officer https://ml.globenewswire.com/media/832f8e23-1a68-4b10-b8aa-a35287e6c2e4/small/patchmd-red-logo-png.png https://www.madagascarhealthpress.com/article/907128730-sotera-health-announces-first-quarter-2026-earnings-release-date Madagascar Health Press en PressRelease 2026-04-21T11:46:03+00:00 Sotera Health Announces First-Quarter 2026 Earnings Release Date https://ml.globenewswire.com/media/a0ec722c-ad65-4f05-a8ae-bc1aa6cc4db4/small/sotera-png.png https://www.madagascarhealthpress.com/article/907126642-plus-therapeutics-regains-compliance-with-nasdaq-minimum-bid-price-requirement Madagascar Health Press en PressRelease 2026-04-21T11:30:00+00:00 Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement  https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://www.madagascarhealthpress.com/article/907127056-corvus-pharmaceuticals-to-host-investor-and-analyst-meeting-on-may-14-2026-to-highlight-soquelitinib-data-being-presented-at-the-society-for Madagascar Health Press en PressRelease 2026-04-21T11:30:00+00:00 Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting https://ml.globenewswire.com/media/d05c16d1-5c24-4242-84b5-aea3951ca251/small/corvus-logo-large-jpg.jpg https://www.madagascarhealthpress.com/article/907127289-briacell-presents-robust-anti-cancer-activity-of-bria-ots-in-preclinical-cancer-models Madagascar Health Press en PressRelease 2026-04-21T11:30:00+00:00 BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models https://ml.globenewswire.com/media/6fd3be2a-b6a2-4f35-a39c-dfd88259d9d0/small/briacell-logo-square-a-jpg.jpg https://www.madagascarhealthpress.com/article/907127504-annual-general-and-special-meeting-of-shareholders-to-be-held-may-7-2026 Madagascar Health Press en PressRelease 2026-04-21T11:30:00+00:00 Annual General and Special Meeting of Shareholders to be held May 7, 2026 https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png https://www.madagascarhealthpress.com/article/907127716-medicenna-presents-positive-data-demonstrating-superior-safety-and-efficacy-potential-of-its-first-in-class-anti-pd-1-x-il-2-bifunctional-superkine Madagascar Health Press en PressRelease 2026-04-21T11:30:00+00:00 Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026 https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png https://www.madagascarhealthpress.com/article/907127966-bpgbio-appoints-former-oxford-pro-vice-chancellor-for-innovation-chas-bountra-ph-d-as-executive-vice-president-and-chief-scientific-officer Madagascar Health Press en PressRelease 2026-04-21T11:05:00+00:00 BPGbio Appoints Former Oxford Pro-Vice Chancellor for Innovation Chas Bountra, Ph.D., as Executive Vice President and Chief Scientific Officer https://ml.globenewswire.com/media/4a0c4e8a-8478-4161-9bc1-cfcdc41c9462/medium/bpgbio-appoints-chas-bountra-ph-d-as-executive-vice-presiden.png https://www.madagascarhealthpress.com/article/907126696-standard-biotools-to-announce-first-quarter-2026-financial-results-on-may-5-2026 Madagascar Health Press en PressRelease 2026-04-21T11:00:00+00:00 Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 https://ml.globenewswire.com/media/122934c3-b763-4386-89d1-3047d0704c17/small/sbt-new-august-2022-logo.png https://www.madagascarhealthpress.com/article/907126767-bioage-reports-positive-phase-1-data-for-bge-102-a-novel-oral-nlrp3-inhibitor-demonstrating-potential-best-in-class-reductions-in-hscrp Madagascar Health Press en PressRelease 2026-04-21T11:00:00+00:00 BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png https://www.madagascarhealthpress.com/article/907127293-eupraxia-pharmaceuticals-reports-positive-nine-month-tissue-health-and-symptom-data-from-the-highest-dose-cohort-in-its-ongoing-phase-1b-2a-resolve Madagascar Health Press en PressRelease 2026-04-21T11:00:00+00:00 Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis  https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.madagascarhealthpress.com/article/907127564-rezolute-to-present-results-from-its-phase-3-sunrize-study-in-congenital-hyperinsulinism-at-the-pediatric-endocrine-society-pes-annual-meeting Madagascar Health Press en PressRelease 2026-04-21T11:00:00+00:00 Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting https://ml.globenewswire.com/media/bbe03de3-6870-4230-b875-d8965a3d1b97/small/rezolute-jpg.jpg https://www.madagascarhealthpress.com/article/907127978-kala-bio-celebrates-trump-executive-order-as-game-changer-for-psychedelic-medicine Madagascar Health Press en PressRelease 2026-04-21T11:00:00+00:00 Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine https://ml.globenewswire.com/media/15db4366-93ba-40fa-b80d-58cbdde3496e/small/kala-bio-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907128029-xortx-meets-nasdaq-continued-listing-requirements Madagascar Health Press en PressRelease 2026-04-21T11:00:00+00:00 XORTX Meets Nasdaq Continued Listing Requirements https://ml.globenewswire.com/media/9898c4f8-b373-438a-abfa-709c4372a061/small/xortx-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907128063-independent-nonclinical-research-on-lasofoxifene-presented-at-american-association-for-cancer-research-annual-meeting-2026-consistent-with-leonabio-s Madagascar Health Press en PressRelease 2026-04-21T11:00:00+00:00 Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data https://ml.globenewswire.com/media/84ac024a-139b-463f-a43f-ed787a66c0fd/small/image1-jpg.jpg https://www.madagascarhealthpress.com/article/907128135-aavantgarde-announces-completion-of-recruitment-in-stella-natural-history-study Madagascar Health Press en PressRelease 2026-04-21T11:00:00+00:00 AAVantgarde announces completion of recruitment in STELLA natural history study https://ml.globenewswire.com/media/e7ffd915-8158-436d-b9fe-8db1cb3597ce/small/logo-png.png https://www.madagascarhealthpress.com/article/907117183-biontech-to-report-first-quarter-2026-financial-results-and-corporate-update-on-may-5-2026 Madagascar Health Press en PressRelease 2026-04-21T10:45:00+00:00 BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/190705-biontech-logo-rgb-dark-green-preferred-0-png.png https://www.madagascarhealthpress.com/article/907117253-biontech-ver-ffentlicht-am-5-mai-2026-ergebnisse-f-r-das-erste-quartal-2026-und-informiert-ber-operativen-fortschritt Madagascar Health Press en PressRelease 2026-04-21T10:45:00+00:00 BioNTech veröffentlicht am 5. Mai 2026 Ergebnisse für das erste Quartal 2026 und informiert über operativen Fortschritt https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/ https://www.madagascarhealthpress.com/article/907117929-avricore-health-achieves-milestones-and-outlines-uk-expansion-roadmap-for-healthtab-platform Madagascar Health Press en PressRelease 2026-04-21T10:30:00+00:00 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform https://ml.globenewswire.com/media/a3e47a88-fedc-4db4-969f-5fe1f028c54a/small/avicorelogo-png.png https://www.madagascarhealthpress.com/article/907117341-cj-partners Madagascar Health Press en PressRelease 2026-04-21T10:00:00+00:00 ダークホース・コンサルティング・グループ、CJ PARTNERS株式会社の買収によりアジア地域でのプレゼンスを強化 https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.madagascarhealthpress.com/article/907117404-dark-horse-consulting-group-s-acquisition-of-cj-partners-provides-regional-expansion Madagascar Health Press en PressRelease 2026-04-21T10:00:00+00:00 Dark Horse Consulting Group’s Acquisition of CJ PARTNERS Provides Regional Expansion https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.madagascarhealthpress.com/article/907117621-hyalex-orthopaedics-announces-fda-510-k-clearance-of-the-hyalex-slalom-mtp-hemiarthroplasty-system Madagascar Health Press en PressRelease 2026-04-21T10:00:00+00:00 Hyalex Orthopaedics Announces FDA 510(k) Clearance of the HYALEX Slalom™ MTP Hemiarthroplasty System https://ml.globenewswire.com/media/2c148840-120a-41be-af54-0ad73f8a4f6b/small/hyalex-logo-vector-recreated-white-border-png.png https://www.madagascarhealthpress.com/article/907117962-nobel-potential-discovery-from-vectorbuilder-scientists-reveals-fundamental-mechanisms-of-development Madagascar Health Press en PressRelease 2026-04-21T10:00:00+00:00 Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development https://ml.globenewswire.com/media/051ef275-dc49-4fe6-bf1c-5736d994e6d3/small/vectorbuilder-logo-en-png.png https://www.madagascarhealthpress.com/article/907117969-preclinical-data-of-novel-b7-h3-adc-icp-b794-unveiled-at-2026-aacr-demonstrating-superior-anti-tumor-activity-and-safety Madagascar Health Press en PressRelease 2026-04-21T10:00:00+00:00 Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveiled at 2026 AACR, Demonstrating Superior Anti-Tumor Activity and Safety https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://www.madagascarhealthpress.com/article/907108228-promatix-biosciences-highlights-the-power-of-its-logic-gated-proteomics-driven-bispecific-discovery-platform-to-expand-the-tumour-selective-target Madagascar Health Press en PressRelease 2026-04-21T09:00:00+00:00 Promatix Biosciences Highlights the Power of its Logic-Gated Proteomics-Driven Bispecific Discovery Platform to Expand the Tumour-Selective Target Space for Next-Generation ADCs at AACR 2026 https://ml.globenewswire.com/media/9974c756-5f06-489e-adfb-6d302f15607d/small/promatix-curve-4c-rgb-png.png https://www.madagascarhealthpress.com/article/907091007-xeltis-receives-ce-mark-for-axess-its-axess-hemodialysis-conduit-as-it-moves-to-commercialization Madagascar Health Press en PressRelease 2026-04-21T07:30:00+00:00 Xeltis receives CE mark for aXess™, its aXess hemodialysis conduit™, as it moves to commercialization https://ml-eu.globenewswire.com/media/dee0d6ab-8850-4503-bdcd-ede435e96729/small/xeltis-youtube-logo-high-res-002-png.png https://www.madagascarhealthpress.com/article/907083330-grady-manual-therapy-ltd-champions-exercise-is-medicine-to-deliver-professional-sports-health-care-to-everyday-athletes-in-hong-kong Madagascar Health Press en PressRelease 2026-04-21T06:17:00+00:00 Grady Manual Therapy Ltd Champions "Exercise is Medicine" to Deliver Professional Sports Health Care to Everyday Athletes in Hong Kong https://ml.globenewswire.com/media/c633e084-7b0e-4176-9e88-920252646685/medium/grady-manual-therapy.jpg https://www.madagascarhealthpress.com/article/907082963-groundbreaking-approaches-such-as-cell-therapies-on-the-horizon-for-transformation-of-neural-hearing-loss-rinri-therapeutics-review1-shows Madagascar Health Press en PressRelease 2026-04-21T06:10:51+00:00 Groundbreaking approaches such as cell therapies on the horizon for transformation of neural hearing loss, Rinri Therapeutics’ review1 shows https://ml-eu.globenewswire.com/media/b9ae33a8-504d-4b72-af5c-e7cc32499f9e/small/news-hold-700x441-png.png https://www.madagascarhealthpress.com/article/907082843-amphista-therapeutics-presents-the-discovery-characterisation-and-chemical-structure-of-amx-883-an-orally-bioavailable-highly-potent-and-selective Madagascar Health Press en PressRelease 2026-04-21T06:00:00+00:00 Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026 https://ml-eu.globenewswire.com/media/d3d2174f-591e-4e13-9a89-363dcbfe5c68/small/amphista-horiz-logo-rgb-1500px-png.png https://www.madagascarhealthpress.com/article/907074659-addex-gabab-pam-candidate-demonstrates-robust-anti-tussive-activity-in-non-human-primate-chronic-cough-model Madagascar Health Press en PressRelease 2026-04-21T05:00:00+00:00 Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model https://ml-eu.globenewswire.com/media/e6c12443-4244-46f9-909c-5ab241bbea41/small/logo-jpg.jpg https://www.madagascarhealthpress.com/article/907057861-rapid-nutrition-establishes-flagship-platform-to-strengthen-multi-channel-strategy-in-australia Madagascar Health Press en PressRelease 2026-04-21T03:05:00+00:00 Rapid Nutrition Establishes Flagship Platform to Strengthen Multi-Channel Strategy in Australia https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://www.madagascarhealthpress.com/article/907042110-enjoin-launches-technology-first-rebrand-for-scalable-revenue-integrity Madagascar Health Press en PressRelease 2026-04-21T01:07:48+00:00 Enjoin Launches Technology-First Rebrand For Scalable Revenue Integrity https://ml.globenewswire.com/media/89b4ff0a-3ba9-4083-9a13-a7e4b0a07d6f/medium/enjoin-launches-technology-first-rebrand-for-scalable-revenu.png https://www.madagascarhealthpress.com/article/907035057-moonbuddy-kids-breathing-guidance-under-investigation-tactile-breathwork-device-claims-get-reviewed Madagascar Health Press en PressRelease 2026-04-21T00:53:42+00:00 Moonbuddy Kids Breathing Guidance Under Investigation: Tactile Breathwork Device Claims Get Reviewed https://zingfast.com/wp-content/uploads/2026/04/Moonbuddy-Kids-Breathing-Guidance.jpg https://www.madagascarhealthpress.com/article/907035030-trt-uk-what-is-trt-and-who-should-take-a-trt-test-a-complete-uk-guide Madagascar Health Press en PressRelease 2026-04-21T00:47:03+00:00 TRT UK - What Is TRT and Who Should Take a TRT Test? A Complete UK Guide https://zingfast.com/wp-content/uploads/2026/04/TRT-UK.png https://www.madagascarhealthpress.com/article/907034966-snorerx-anti-snoring-mouthpiece-claims-evaluated-doctor-recommended-adjustable-mouthguard-for-safer-airway-breathing-overnight Madagascar Health Press en PressRelease 2026-04-21T00:35:09+00:00 SnoreRX Anti-Snoring Mouthpiece Claims Evaluated: Doctor-Recommended Adjustable Mouthguard for Safer Airway Breathing Overnight https://zingfast.com/wp-content/uploads/2026/04/SnoreRX-Anti-Snoring-Mouthpiece.jpg https://www.madagascarhealthpress.com/article/907021337-moonbird-claims-evaluated-guided-breathing-therapy-device-for-meditation-like-calming-benefits-for-relaxation-sleep-support Madagascar Health Press en PressRelease 2026-04-20T23:13:35+00:00 Moonbird Claims Evaluated: Guided Breathing Therapy Device for Meditation-Like Calming Benefits for Relaxation & Sleep Support https://zingfast.com/wp-content/uploads/2026/04/Moodbird.jpg https://www.madagascarhealthpress.com/article/907021232-essential-pharma-renaissance-pharma-limited-daretabart-hu1418k322a-fda-ind Madagascar Health Press en PressRelease 2026-04-20T23:00:00+00:00 Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定，并通过 IND 审评 https://ml-eu.globenewswire.com/media/31276511-f379-4a7a-90b6-af9fc9ac2aa0/small/66795319ca361c8d044a2cc6-essential-pharma-master-logo-png.png https://www.madagascarhealthpress.com/article/907015146-provectus-biopharmaceuticals-to-hold-2026-annual-meeting-of-stockholders-at-perkins-place-its-planned-new-headquarters-in-knoxville-tennessee Madagascar Health Press en PressRelease 2026-04-20T22:09:00+00:00 Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee https://ml.globenewswire.com/media/7cd1d796-f4d3-43f7-8e2b-eb51dc04a073/small/new-logo-png.png https://www.madagascarhealthpress.com/article/907007985-enara-bio-presents-first-in-class-darkfox-targeting-bispecific-t-cell-engager-ena101-in-oral-presentation-at-aacr-2026-showcasing-breakthrough Madagascar Health Press en PressRelease 2026-04-20T21:30:00+00:00 Enara Bio Presents First-in-Class DARKFOX-Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential in Solid Tumor Immunotherapy https://ml-eu.globenewswire.com/media/e94da9bc-a053-4a2f-8d29-c57dba971380/small/logo-png.PNG https://www.madagascarhealthpress.com/article/907008228-aktualisierung-bvi-gibt-bekannt-dass-virtuoso-eine-neue-chirurgische-plattform-mit-doppelfunktion-die-ce-kennzeichnung-gem-eu-mdr-erhalten Madagascar Health Press en PressRelease 2026-04-20T21:28:54+00:00 AKTUALISIERUNG -- BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat https://ml.globenewswire.com/media/NjNkNTUyMTQtMGZiYS00MTczLTkxNDYtN2IxMmI2YTU0ZmMyLTEyNjQwMzItMjAyNi0wNC0yMC1kZQ==/tiny/BVI-Medical-Inc-.png https://www.madagascarhealthpress.com/article/907008243-mise-jour-bvi-annonce-l-obtention-du-marquage-ce-au-titre-du-r-glement-europ-en-sur-les-dispositifs-m-dicaux-pour-virtuoso-une-toute-nouvelle Madagascar Health Press en PressRelease 2026-04-20T21:28:54+00:00 MISE À JOUR -- BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction https://ml.globenewswire.com/media/NjNkNTUyMTQtMGZiYS00MTczLTkxNDYtN2IxMmI2YTU0ZmMyLTEyNjQwMzItMjAyNi0wNC0yMC1mcg==/tiny/BVI-Medical-Inc-.png https://www.madagascarhealthpress.com/article/907008038-bastiongpt-named-top-ai-platform-for-clinical-psychology-report-writing Madagascar Health Press en PressRelease 2026-04-20T21:13:00+00:00 BastionGPT Named Top AI Platform for Clinical Psychology Report Writing https://pressranger.s3.us-west-1.amazonaws.com/3234411/Top-AI-Report-Writers-Hero.jpg https://www.madagascarhealthpress.com/article/907007986-junshi-biosciences-presents-results-from-js207-pd-1-vegf-bsab-phase-2-combo-studies-and-js212-egfr-her3-adc-fih-phase-1-2-study-at-aacr-2026 Madagascar Health Press en PressRelease 2026-04-20T21:00:00+00:00 Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026 https://ml.globenewswire.com/media/815f9c91-bb76-4c14-b3e9-0685275600cc/small/junshi-topalliance-logo-png.png https://www.madagascarhealthpress.com/article/907000723-cvrx-announces-nomination-of-michael-dale-for-election-to-the-board-of-directors Madagascar Health Press en PressRelease 2026-04-20T20:30:00+00:00 CVRx Announces Nomination of Michael Dale for Election to the Board of Directors https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png https://www.madagascarhealthpress.com/article/907000759-jatt-ii-acquisition-corp-announces-closing-of-60-000-000-initial-public-offering Madagascar Health Press en PressRelease 2026-04-20T20:30:00+00:00 JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering https://ml.globenewswire.com/media/6124930b-cb04-4490-8614-def6ec191d09/small/1b-for-pr-jatt-2-png.png https://www.madagascarhealthpress.com/article/907000697-spectral-ai-announces-annual-meeting-of-stockholders Madagascar Health Press en PressRelease 2026-04-20T20:15:00+00:00 Spectral AI Announces Annual Meeting of Stockholders https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907000898-si-bone-to-report-first-quarter-2026-financial-results-on-may-11-2026 Madagascar Health Press en PressRelease 2026-04-20T20:09:00+00:00 SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/1630843d-d109-4819-9c6f-455c684690ba/small/sibn-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907001325-bbot-granted-u-s-fda-fast-track-designation-for-bbo-11818-for-the-treatment-of-adult-patients-with-advanced-kras-mutant-pancreatic-ductal Madagascar Health Press en PressRelease 2026-04-20T20:06:48+00:00 BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://www.madagascarhealthpress.com/article/906998846-abivax-annual-ordinary-and-extraordinary-general-meeting-of-may-11-2026-availability-of-the-preparatory-documents Madagascar Health Press en PressRelease 2026-04-20T20:05:00+00:00 Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png https://www.madagascarhealthpress.com/article/906998866-regeneron-announces-investor-conference-presentations Madagascar Health Press en PressRelease 2026-04-20T20:05:00+00:00 Regeneron Announces Investor Conference Presentations https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907000274-geron-corporation-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Madagascar Health Press en PressRelease 2026-04-20T20:05:00+00:00 Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907000281-ceribell-to-report-first-quarter-2026-financial-results-on-may-11-2026 Madagascar Health Press en PressRelease 2026-04-20T20:05:00+00:00 Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/937c5c00-41f8-45ff-b294-5f9c3f6ab2cf/small/cbll-square-logo-500x500-png.png https://www.madagascarhealthpress.com/article/907000699-amwell-to-report-first-quarter-2026-operating-results Madagascar Health Press en PressRelease 2026-04-20T20:05:00+00:00 Amwell® to report first quarter 2026 operating results https://ml.globenewswire.com/media/ff1989f5-0a6a-4e00-99dc-cb29a818aca5/small/amwell-logo-blue-2023-v02-rgb-2-png.png https://www.madagascarhealthpress.com/article/907000869-trevi-therapeutics-announces-closing-of-173-million-underwritten-offering-and-full-exercise-by-underwriters-of-option-to-purchase-additional-shares Madagascar Health Press en PressRelease 2026-04-20T20:05:00+00:00 Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://www.madagascarhealthpress.com/article/907000933-equillium-to-participate-in-oppenheimer-s-2026-innovation-on-the-island-event Madagascar Health Press en PressRelease 2026-04-20T20:05:00+00:00 Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event https://ml.globenewswire.com/media/14ce766d-e697-461f-a27c-c1ee49c0eeff/small/equillium-logo-360x180-jpg.jpg https://www.madagascarhealthpress.com/article/907001167-kailera-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares Madagascar Health Press en PressRelease 2026-04-20T20:05:00+00:00 Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://www.madagascarhealthpress.com/article/907000930-clearmind-medicine-welcomes-president-trump-s-executive-order-as-a-historic-catalyst-for-psychedelic-innovation-and-veteran-mental-health-care Madagascar Health Press en PressRelease 2026-04-20T20:03:00+00:00 Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.madagascarhealthpress.com/article/907000821-fibrobiologics-compliant-with-all-nasdaq-listing-requirements Madagascar Health Press en PressRelease 2026-04-20T20:01:00+00:00 FibroBiologics Compliant with All Nasdaq Listing Requirements https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.madagascarhealthpress.com/article/907000730-cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Madagascar Health Press en PressRelease 2026-04-20T20:00:00+00:00 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.madagascarhealthpress.com/article/907000929-nadp-appoints-first-dentist-to-lead-dental-informatics-program Madagascar Health Press en PressRelease 2026-04-20T20:00:00+00:00 NADP appoints first dentist to lead dental informatics program https://ml.globenewswire.com/media/4a10cf41-2ae9-4a40-a33e-49e2ed33e40f/small/nadp-logo-horizontal-2024-final-jpg.jpg https://www.madagascarhealthpress.com/article/907000963-kfsh-se-une-al-c3-davos-of-healthcare-2026-en-sunnyvale-california-como-socio-estrat-gico-global Madagascar Health Press en PressRelease 2026-04-20T19:51:30+00:00 KFSH se une al C3 Davos of Healthcare™ 2026 en Sunnyvale, California, como socio estratégico global https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.madagascarhealthpress.com/article/907000964-kfsh-participa-da-c3-davos-of-healthcare-2026-em-sunnyvale-calif-rnia-como-parceira-estrat-gica-global Madagascar Health Press en PressRelease 2026-04-20T19:51:30+00:00 KFSH Participa da C3 Davos of Healthcare™ 2026 em Sunnyvale, Califórnia, como Parceira Estratégica Global https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.madagascarhealthpress.com/article/906993005-ab-science-nouvelle-publication-sur-medrxiv-d-montrant-des-b-n-fices-substantiels-en-termes-de-survie-et-de-qualit-de-vie-pr-serv-e-avec-le Madagascar Health Press en PressRelease 2026-04-20T19:32:18+00:00 AB Science : Nouvelle publication sur medrxiv démontrant des bénéfices substantiels en termes de survie et de qualité de vie préservée avec le masitinib chez les patients atteints de SLA https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/ https://www.madagascarhealthpress.com/article/906993019-ab-science-new-publication-on-medrxiv-demonstrating-substantial-survival-benefits-and-preserved-quality-of-life-with-masitinib-in-als-patients Madagascar Health Press en PressRelease 2026-04-20T19:32:18+00:00 AB Science: New publication on medrxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in ALS patients https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/logo-jpg.jpg https://www.madagascarhealthpress.com/article/906987447-flyte-emerges-as-direct-beneficiary-as-rising-fuel-costs-drive-airline-retreat-from-short-haul-routes Madagascar Health Press en PressRelease 2026-04-20T18:50:00+00:00 FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://www.madagascarhealthpress.com/article/906982674-lung-cancer-therapeutics-market-to-reach-49-5-billion-by-2030-driven-by-rising-cancer-incidence-and-r-d-investment-surge Madagascar Health Press en PressRelease 2026-04-20T18:19:26+00:00 Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&D Investment Surge https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.madagascarhealthpress.com/article/906982665-herz-p1-smart-bpm-under-investigation-clinical-grade-blood-pressure-monitoring-for-valuable-at-home-health-tracking-support Madagascar Health Press en PressRelease 2026-04-20T18:11:55+00:00 Herz P1 Smart BPM Under Investigation: Clinical-Grade Blood Pressure Monitoring for Valuable At-Home Health Tracking Support https://zingfast.com/wp-content/uploads/2026/04/Herz-P1-Smart-BPM.jpg https://www.madagascarhealthpress.com/article/906982687-viriflow-claims-evaluated-the-prostate-supporting-formula-for-men-that-actually-works-in-viri-flow-drops-reviewed Madagascar Health Press en PressRelease 2026-04-20T18:09:54+00:00 ViriFlow Claims Evaluated: The Prostate-Supporting Formula for Men That Actually Works in Viri Flow Drops Reviewed https://zingfast.com/wp-content/uploads/2026/04/ViriFlow-1.jpg https://www.madagascarhealthpress.com/article/906972983-lirum-therapeutics-announces-positive-lx-101-data-selected-for-presentation-at-the-2026-american-association-for-cancer-research-aacr-annual-meeting Madagascar Health Press en PressRelease 2026-04-20T17:00:00+00:00 Lirum Therapeutics Announces Positive LX-101 Data Selected for Presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting https://ml.globenewswire.com/media/09223099-97d9-4c04-8b22-ce639c0fd876/small/lirum-therapeutics-inc-logo-jpg.jpg https://www.madagascarhealthpress.com/article/906972380-stiltz-homelifts-opens-first-u-s-showroom-in-denver-showcasing-innovative-home-elevator-solutions Madagascar Health Press en PressRelease 2026-04-20T16:21:48+00:00 Stiltz Homelifts Opens First U.S. Showroom in Denver, Showcasing Innovative Home Elevator Solutions https://ml.globenewswire.com/media/NTcyZDQ0MTQtY2I4OC00NWE0LTlhZDQtZmI5MzRmODc5N2E4LTUwMDE1MTA0My0yMDI2LTA0LTIwLWVu/tiny/Stiltz-Homelifts.png https://www.madagascarhealthpress.com/article/906967650-genfit-publication-of-the-2026-extra-financial-report-fiscal-year-2025 Madagascar Health Press en PressRelease 2026-04-20T16:00:00+00:00 GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025) https://ml-eu.globenewswire.com/media/NWQ4ZDk0NzEtNGJjYy00N2I0LTljZTgtNTVlNGMzMWE3NmIyLTEwMTEyNjgtMjAyNi0wNC0yMC1lbg==/tiny/GENFIT-S-A-.png https://www.madagascarhealthpress.com/article/906967654-genfit-publication-du-rapport-de-performance-extra-financi-re-2026-exercice-2025 Madagascar Health Press en PressRelease 2026-04-20T16:00:00+00:00 GENFIT : Publication du rapport de performance extra-financière 2026 (exercice 2025) https://ml-eu.globenewswire.com/media/NWQ4ZDk0NzEtNGJjYy00N2I0LTljZTgtNTVlNGMzMWE3NmIyLTEwMTEyNjgtMjAyNi0wNC0yMC1mcg==/tiny/GENFIT-S-A-.png https://www.madagascarhealthpress.com/article/906967984-une-analyse-m-dico-conomique-la-premi-re-du-genre-montre-que-le-recours-pr-coce-des-tests-de-diagnostic-rapides-pour-soigner-le-sepsis-pourrait Madagascar Health Press en PressRelease 2026-04-20T15:48:14+00:00 Une analyse médico-économique, la première du genre, montre que le recours précoce à des tests de diagnostic rapides pour soigner le sepsis pourrait sauver des milliers de vies au Canada et réduire les coûts du système de santé dans les pays du G… https://ml.globenewswire.com/media/a5be803c-994c-40a9-9736-fbddf2068664/small/ https://www.madagascarhealthpress.com/article/906968109-first-of-its-kind-health-economic-analysis-shows-early-use-of-fast-diagnostics-in-sepsis-care-could-save-thousands-of-lives-in-canada-and-reduce Madagascar Health Press en PressRelease 2026-04-20T15:48:14+00:00 First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives in Canada and Reduce Health System Costs Across G7 Countries https://ml.globenewswire.com/media/a5be803c-994c-40a9-9736-fbddf2068664/small/bmx-hi-res-png-png.png https://www.madagascarhealthpress.com/article/906967981-allsup-employment-services-highlights-tax-incentives-for-employers-hiring-through-ticket-to-work-program Madagascar Health Press en PressRelease 2026-04-20T15:45:44+00:00 Allsup Employment Services Highlights Tax Incentives For Employers Hiring Through Ticket To Work Program https://ml.globenewswire.com/media/NWExNjVhY2ItMGU4YS00MzU3LTgyNjItM2YyYWI1YjNlZTZiLTEwOTcwODEtMjAyNi0wNC0yMC1lbg==/tiny/Allsup.png https://www.madagascarhealthpress.com/article/906967852-onward-medical-publishes-closing-of-bookbuild-offering Madagascar Health Press en PressRelease 2026-04-20T15:45:00+00:00 ONWARD Medical Publishes Closing of Bookbuild Offering https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png https://www.madagascarhealthpress.com/article/906963267-naomi-ruth-cohen-institute-for-mental-health-education-to-host-annual-conference-addressing-the-growing-crisis-of-loneliness Madagascar Health Press en PressRelease 2026-04-20T15:15:51+00:00 Naomi Ruth Cohen Institute For Mental Health Education to Host Annual Conference Addressing the Growing Crisis of Loneliness https://ml.globenewswire.com/media/dbf190a7-e0c0-4b88-843a-d7e31bf57b45/small/the-chicago-school-logo.png https://www.madagascarhealthpress.com/article/906958920-global-vascular-access-device-market-to-reach-usd-8-68-billion-by-2031-marketsandmarkets Madagascar Health Press en PressRelease 2026-04-20T14:30:00+00:00 Global Vascular Access Device Market to Reach USD 8.68 Billion by 2031 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.madagascarhealthpress.com/article/906954710-alayacare-and-eitan-medical-partner-to-eliminate-manual-transcription-for-home-infusion-nurses Madagascar Health Press en PressRelease 2026-04-20T14:14:14+00:00 AlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nurses https://ml.globenewswire.com/media/80920392-a416-454f-9f6c-c63983a6924e/medium/alayacare-and-eitan-medical-partner-to-eliminate-manual-tran.png https://www.madagascarhealthpress.com/article/906954306-baba-appoints-former-mount-sinai-executive-director-to-lead-clinical-operations Madagascar Health Press en PressRelease 2026-04-20T14:00:00+00:00 Baba Appoints Former Mount Sinai Executive Director to Lead Clinical Operations https://ml.globenewswire.com/media/1152e949-0f9a-4ff0-96e1-bcdae32214aa/small/baba-logo-blue-1-png.png https://www.madagascarhealthpress.com/article/906954500-viewsml-secures-funding-to-accelerate-commercialization-of-ai-driven-virtual-biomarker-staining-platform Madagascar Health Press en PressRelease 2026-04-20T14:00:00+00:00 ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform https://ml.globenewswire.com/media/8484a3fc-fc06-4cd9-bcd5-2083fa5c8637/small/logo-horizontal-positive-png.png https://www.madagascarhealthpress.com/article/906954630-bvi-announces-ce-mark-under-eu-mdr-for-virtuoso-a-brand-new-dual-function-surgical-platform Madagascar Health Press en PressRelease 2026-04-20T14:00:00+00:00 BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.madagascarhealthpress.com/article/906954618-tilray-brands-marks-4-20-reaffirming-its-leadership-in-cannabis-and-commitment-to-advancing-medical-care Madagascar Health Press en PressRelease 2026-04-20T13:56:27+00:00 Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://www.madagascarhealthpress.com/article/906950148-hinweis-zum-nichtbeachten-bvi-medical-inc Madagascar Health Press en PressRelease 2026-04-20T13:46:44+00:00 HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc. https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.madagascarhealthpress.com/article/906950152-avis-ignorer-bvi-medical-inc Madagascar Health Press en PressRelease 2026-04-20T13:46:44+00:00 AVIS À IGNORER -- BVI Medical, Inc. https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.madagascarhealthpress.com/article/906950084-3-2-bn-medical-radiation-shielding-market-forecasts-to-2034-rising-more-imaging-and-therapy-procedures-due-to-growing-chronic-diseases-and Madagascar Health Press en PressRelease 2026-04-20T13:37:26+00:00 $3.2+ BN Medical Radiation Shielding Market Forecasts to 2034: Rising More Imaging and Therapy Procedures Due to Growing Chronic Diseases and Increasing Risk Awareness https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://www.madagascarhealthpress.com/article/906950102-vystar-enters-into-binding-letter-of-intent-to-acquire-50-interest-in-r3alm-inc Madagascar Health Press en PressRelease 2026-04-20T13:22:43+00:00 Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc. https://ml.globenewswire.com/media/08188699-078a-4d6e-ae46-c56120bb0435/small/logo-jpg.jpg https://www.madagascarhealthpress.com/article/906946311-anaptys-completes-separation-of-first-tracks-biotherapeutics-and-now-exclusively-manages-gsk-and-vanda-financial-collaborations Madagascar Health Press en PressRelease 2026-04-20T13:15:00+00:00 Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://www.madagascarhealthpress.com/article/906946313-first-tracks-biotherapeutics-debuts-on-nasdaq-to-advance-therapies-for-autoimmune-diseases Madagascar Health Press en PressRelease 2026-04-20T13:15:00+00:00 First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases https://ml.globenewswire.com/media/7165e7cf-d98b-4a0f-90f3-3cd8f3a6b320/small/ftb-logo-png.png https://www.madagascarhealthpress.com/article/906946476-intelligent-bio-solutions-initiates-validation-study-for-rapid-drug-screening-cartridge-targeting-70-faster-results Madagascar Health Press en PressRelease 2026-04-20T13:15:00+00:00 Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results https://ml.globenewswire.com/media/d4eaef42-9420-48b7-8019-0285720d678c/small/ibs-primary-logo-blue-png.png https://www.madagascarhealthpress.com/article/906945549-orion-pharma-s-odm-212-granted-orphan-drug-designation-in-mesothelioma-by-the-us-fda Madagascar Health Press en PressRelease 2026-04-20T13:00:00+00:00 Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://www.madagascarhealthpress.com/article/906945573-orion-pharman-odm-212-molekyyli-on-saanut-fda-n-harvinaisl-kestatuksen-orphan-drug-designation-mesoteliooman-hoidossa Madagascar Health Press en PressRelease 2026-04-20T13:00:00+00:00 Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/ https://www.madagascarhealthpress.com/article/906945991-rpharmy-completes-soc-2-type-ii-audit-reinforcing-its-commitment-to-data-security-in-healthcare Madagascar Health Press en PressRelease 2026-04-20T13:00:00+00:00 Rpharmy Completes SOC 2® Type II Audit, Reinforcing Its Commitment to Data Security in Healthcare https://ml.globenewswire.com/media/d4e2107a-158e-47f0-83ff-c3ff9cca678d/small/rpharmy-charcoal-logo-png.png https://www.madagascarhealthpress.com/article/906946091-immuneering-presents-genetic-data-at-aacr-annual-meeting-demonstrating-mechanism-to-improve-durability-and-survival-supporting-use-of-atebimetinib-in Madagascar Health Press en PressRelease 2026-04-20T13:00:00+00:00 Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg https://www.madagascarhealthpress.com/article/906946305-scilex-holding-company-announces-its-board-of-directors-approved-a-dividend-of-dream-bowl-i-meme-coin-tokens-to-holders-of-common-stock-and-other Madagascar Health Press en PressRelease 2026-04-20T13:00:00+00:00 Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026 https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg https://www.madagascarhealthpress.com/article/906946413-gh-research-welcomes-white-house-executive-order-to-accelerate-medical-treatments-for-serious-mental-illness Madagascar Health Press en PressRelease 2026-04-20T13:00:00+00:00 GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness https://ml.globenewswire.com/media/a1baa9e5-3408-4f8f-b4aa-7c4204e0971b/small/full-colour-png.png